Significantly lower infection fatality rates associated with SARS-CoV-2 Omicron (B.1.1.529) infection in children and young people: Active, prospective national surveillance, January-March 2022, England
J Infect. 2023 Apr;86(4):397-398.
doi: 10.1016/j.jinf.2023.01.032.
Epub 2023 Jan 24.
1 Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
2 Joint Modelling Team (JMT), UK Health Security Agency, UK; Emergency Preparedness, Response and Resilience, UK Health Security Agency, Porton Down, SP4 0JG, UK.
3 Joint Modelling Team (JMT), UK Health Security Agency, UK; MRC Biostatistics Unit, University of Cambridge, School of Clinical Medicine, Cambridge Institute of Public Health, Cambridge, United Kingdom; Statistical Modelling and Economics, UK Health Security Agency, Colindale, United Kingdom.
4 MRC Biostatistics Unit, University of Cambridge, School of Clinical Medicine, Cambridge Institute of Public Health, Cambridge, United Kingdom.
5 Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, United Kingdom; Paediatric Infectious Diseases Research Group, St George's University of London, London, United Kingdom.
6 Immunisation and Vaccine-Preventable Diseases Division, UK Health Security Agency, London, United Kingdom; Paediatric Infectious Diseases Research Group, St George's University of London, London, United Kingdom. Electronic address: shamez.ladhani@ukhsa.gov.uk.